CD8A and neoplasm: Previous research has demonstrated that PD-1 blockade can transiently reduce tumor growth and metastasis in syngeneic tumor models by increasing CD8+ tumor-infiltrating lymphocytes (TILs) and decreasing exhausted CD8+TILs.